These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1194 related articles for article (PubMed ID: 16640529)

  • 21. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
    Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
    Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
    Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD
    Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late graft dysfunction after liver transplantation for primary biliary cirrhosis: disease recurrence versus chronic graft rejection.
    Lerut JP; Zimmermann A; Gertsch P
    Am J Gastroenterol; 1994 Oct; 89(10):1896-8. PubMed ID: 7942692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis.
    Van de Water J; Gerson LB; Ferrell LD; Lake JR; Coppel RL; Batts KP; Wiesner RH; Gershwin ME
    Hepatology; 1996 Nov; 24(5):1079-84. PubMed ID: 8903379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Living donor liver transplantation for primary biliary cirrhosis: retrospective analysis of 50 patients in a single center.
    Hasegawa K; Sugawara Y; Imamura H; Ikeda M; Kokudo N; Makuuchi M
    Transpl Int; 2005 Jul; 18(7):794-9. PubMed ID: 15948857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results after liver transplantation.
    Pfitzmann R; Nüssler NC; Hippler-Benscheidt M; Neuhaus R; Neuhaus P
    Transpl Int; 2008 Mar; 21(3):234-46. PubMed ID: 18031464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL
    Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
    Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.
    Farges O; Saliba F; Farhamant H; Samuel D; Bismuth A; Reynes M; Bismuth H
    Hepatology; 1996 Feb; 23(2):240-8. PubMed ID: 8591847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity.
    Manousou P; Arvaniti V; Tsochatzis E; Isgro G; Jones K; Shirling G; Dhillon AP; O'Beirne J; Patch D; Burroughs AK
    Liver Transpl; 2010 Jan; 16(1):64-73. PubMed ID: 19866449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group.
    Poupon RE; Bonnand AM; Chrétien Y; Poupon R
    Hepatology; 1999 Jun; 29(6):1668-71. PubMed ID: 10347106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of steroid-free immunosuppression with tacrolimus and daclizumab in liver transplant recipients: 6-year follow-up in a single center.
    Foroncewicz B; Mucha K; Ryszkowska E; Ciszek M; Ziółkowski J; Porowski D; Krawczyk M; Paczek L
    Transplant Proc; 2009 Oct; 41(8):3103-6. PubMed ID: 19857686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients.
    Testa G; Crippin JS; Netto GJ; Goldstein RM; Jennings LW; Brkic BS; Brooks BK; Levy MF; Gonwa TA; Klintmalm GB
    Liver Transpl; 2000 Sep; 6(5):553-61. PubMed ID: 10980053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.
    Trouillot TE; Shrestha R; Kam I; Wachs M; Everson GT
    Liver Transpl Surg; 1999 Sep; 5(5):375-80. PubMed ID: 10477838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation.
    Neuberger J; Gunson B; Hubscher S; Nightingale P
    Liver Transpl; 2004 Apr; 10(4):488-91. PubMed ID: 15048790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation.
    Balan V; Batts KP; Porayko MK; Krom RA; Ludwig J; Wiesner RH
    Hepatology; 1993 Dec; 18(6):1392-8. PubMed ID: 8244263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.
    Graziadei IW; Wiesner RH; Marotta PJ; Porayko MK; Hay JE; Charlton MR; Poterucha JJ; Rosen CB; Gores GJ; LaRusso NF; Krom RA
    Hepatology; 1999 Nov; 30(5):1121-7. PubMed ID: 10534330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrence of primary sclerosing cholangitis in patients after liver transplantation.
    Ołdakowska-Jedynak U; Nowak M; Mucha K; Foroncewicz B; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Patkowski W; Górnicka B; Paczkowska A; Michałowicz B; Pilecki T; Pawlak J; Krawczyk M; Paczek L
    Transplant Proc; 2006; 38(1):240-3. PubMed ID: 16504713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation.
    Ercolani G; Grazi GL; Ravaioli M; Del Gaudio M; Cescon M; Varotti G; Ramacciato G; Vetrone G; Zanello M; Pinna AD
    Liver Transpl; 2006 Jul; 12(7):1104-11. PubMed ID: 16710855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver transplantation for Wilson's disease.
    Sevmis S; Karakayali H; Aliosmanoglu I; Yilmaz U; Ozcay F; Torgay A; Arslan G; Haberal M
    Transplant Proc; 2008; 40(1):228-30. PubMed ID: 18261593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.